Area of research
Endocrinology, Diabetes and Metabolism · Oncology
Research interest
Research focused on Thyroid carcinoma and Metastasis, with related work in Cystoscopy, Germline mutation, Cancer research. Notable publications include 'miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes', 'Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine', and 'Predictive factors of outcome in poorly differentiated thyroid carcinomas'.
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
Prevalence and clinical correlations of <i>SF3B1</i> variants in lactotroph tumours
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors
Role of gene sequencing in classifying struma ovarii: <i>BRAF</i> p.<scp>G469A</scp> mutation and <i>TERT</i> promoter alterations favour malignant struma ovarii
Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors
Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review
Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes
Predictive factors of outcome in poorly differentiated thyroid carcinomas
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
Molecular testing of <i>BRAF, RAS</i> and <i>TERT</i> on thyroid FNAs with indeterminate cytology improves diagnostic accuracy
The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome